Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Kimia Farma Tbk (KAEF) vs Reksa Dana Premier ETF Indonesia Consumer (XIIC)

Kimia Farma TbkTrading
Reksa Dana Premier ETF Indonesia ConsumerTrading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Kimia Farma Tbk dan Reksa Dana Premier ETF Indonesia Consumer: Kimia Farma Tbk diperdagangkan di Rp454 (kapitalisasi pasar 2,53 T, volume 24 jam 524 rb), sedangkan Reksa Dana Premier ETF Indonesia Consumer diperdagangkan di Rp735 (kapitalisasi pasar 1,61 M, volume 24 jam 29,7 rb). Perbedaan utamanya: Kimia Farma Tbk jauh lebih besar — sekitar 1571,4× kapitalisasi pasar Reksa Dana Premier ETF Indonesia Consumer, dan Kimia Farma Tbk lebih aktif diperdagangkan (524 rb vs 29,7 rb). Mana yang lebih baik tergantung tujuan investasimu.

KAEFXIIC
Kapitalisasi Pasar
2,53 T1,61 M
Volume
524 rb29,7 rb
Lot
5,24 rb297
Perputaran
236,25 jt22,22 jt
Harga Rata-rata
450,87748,06
Nilai Transaksi
236,25 jt22,22 jt
Harga Ekuilibrium Indikatif
454
Volume Ekuilibrium Indikatif
1

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

KAEF
Lihat detail

Tentang Kimia Farma Tbk

PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.

Selengkapnya di halaman KAEF

Tentang Reksa Dana Premier ETF Indonesia Consumer

Selengkapnya di halaman XIIC